Impact of Hinge Motion on Stent Edge-related Restenosis after Right Coronary Artery Treatment in the Current Drug-Eluting Stent Era

Impact of Hinge Motion on Stent Edge-related Restenosis after Right Coronary Artery Treatment in the Current Drug-Eluting Stent Era - Hinge Motion and Stent Edge-related Restenosis

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000041264

Enrollment

300

Registered

2020-07-31

Start date

2019-04-02

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary artery disease

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who were performed percutaneous coronary intervention for right coronary artery with drug eluting stents after 2nd generation from March 2009 to March 2019 at NTT medical center Tokyo

Exclusion criteria

Exclusion criteria: Patients without follow-up coronary angiography

Design outcomes

Primary

Measure	Time frame
Stent edge-related restenosis at follow-up coronary angiography	—

Secondary

Measure	Time frame
Target lesion revascularization, target vessel myocardial infarction	—

Countries

Japan

Contacts

Public ContactTakahiro Jimba

NTT Medical Center Tokyo Division of cardiology

blackjtaka@yahoo.co.jp03-3448-6111

Outcome results